Pricing Log in Create free account

Lakefront Biotherapeutics - Sponsored ADR (LKFT) vs Replimune Group, Inc. (REPL)

Lakefront Biotherapeutics - Sponsored ADR and Replimune Group, Inc. are both Biotechnology companies. Lakefront Biotherapeutics - Sponsored ADR and Replimune Group, Inc. are of similar size ($2.2B and $2.2B). Replimune Group, Inc. has the higher net margin (0.00% vs −6.81%) and the lower return on invested capital (−928.3% vs 0.00%). Across the 13 metrics below, Lakefront Biotherapeutics - Sponsored ADR leads on 10 and Replimune Group, Inc. on 3.

Valuation

Metric LKFT REPL Biotechnology median
P/E n/m n/m 11.58
P/S 7.79 n/m 9.61
P/B 0.58 11.24 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA 0.96 n/m 0.72
EV/Sales (1.42) n/m 9.43
Earnings yield (0.85%) (12.77%) (32.28%)
Free cash flow yield (27.15%) (10.68%) (22.27%)

Profitability

Metric LKFT REPL Biotechnology median
Gross margin 89.75% 0.00% 68.81%
Operating margin (90.11%) 0.00% 0.00%
Net margin (6.81%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (115.80%) (50.30%)
Return on assets 0.00% (71.01%) (45.47%)
Return on invested capital 0.00% (928.27%) 0.00%

Growth

Metric LKFT REPL Biotechnology median
Revenue growth (TTM) (52.22%) — 6.78%
EPS growth (last fiscal year) 355.37% (10.10%) 29.88%
Revenue growth, 5-year CAGR 15.75% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LKFT REPL Biotechnology median
Debt to equity 0.00 0.59 0.00
Current ratio 32.84 7.11 4.74
Net debt to EBITDA (8.53) 0.51 1.01

Dividend

Metric LKFT REPL Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric LKFT REPL Biotechnology median
Market cap 2.19b 2.21b 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack